Bloodwork question about huperzine A. Baseline, five years in, and the numbers moved in a direction I did not expect.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
If you need three other compounds to notice the first one, you have not tested the first one.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Willing to accept that my own experience is the weakest evidence in the room.
Baseline first. Same for me with huperzine A, unfortunately.
Stupid question: how do you know whether what is in the vial matches the label at all?
Same here.